HighTower Advisors LLC raised its position in Teva Pharmaceutical Industries Limited (NYSE:TEVA – Free Report) by 32.3% in ...

FIIs have been steering their focus from large-cap stocks to select small-cap names, signaling a change in market dynamics. While their growing stakes reflect confidence, small-cap stocks come with ...

Merck KGaA operates in three key segments: healthcare, life science, and electronics. Over the past decade, strategic acquisitions and divestments have strengthened its position in these industries, ...

The deal is the latest in a series of Sanofi investments in its immunology portfolio. According to Sanfoi, DR-0201 can ...

Lazard acted as the exclusive financial advisor to Paratek Pharmaceuticals, and Skadden, Arps, Slate, Meagher & Flom LLP is serving as legal advisor. Evercore acted as the exclusive financial advisor ...

Purdue Pharma headquarters at 201 Tresser Boulevard in Stamford. STAMFORD – Purdue Pharma L.P.’s owners will distribute about $7.5 billion ...

Knight Therapeutics Inc. (TSX: GUD) ("Knight" or "the Company"), a pan-American (ex-US) specialty pharmaceutical company, today reported financial results ...

Jeremy Siegel's book, 'Stocks for the Long-run' takes a look at the best performing stock in the last 8 decades. When ...

Cox highlighted the importance of bespoke solutions tailored to specific pharmaceutical assets. "These are world-class assets that deserve really crafted experiences," he stated. He noted that ...

Materials testing specialist ALS Limited is due to report fiscal 2025 results on May 27, 2025. It has not changed guidance for modest improvement in underlying fiscal 2025 NPAT and dividends, and ...

Becker’s asked pharmacy executives from hospitals and health systems across the U.S. to share their biggest lesson from the ...

"The clinical promise of pocenbrodib, our potential best-in-class CBP/p300 inhibitor, lies not only in its remarkable efficacy in resistant prostate cancer models, but also in our sophisticated ...